Cite
HARVARD Citation
Acosta, C. et al. (2021). Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden. Journal of medical economics. pp. 770-780. [Online].